Showing results (1891-1900 of 2,383) with videos related to
Sort By:
Pageof 239
Lancet (London, England)|August 5, 1995
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomasO W Press, J F Eary, F R Appelbaum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myelomaW I Bensinger, C D Buckner, R A Clift, et al.Clinical Nuclear Medicine|December 14, 2011
Ga-68 DOTA-NOC uptake in the pancreas: pathological and physiological patternsYodphat Krausz, Rina Rubinstein, Liat Appelbaum, et al.The International Journal of Cardiovascular Imaging|November 23, 2020
Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET studyKalie Y Kebed, Spencer V Carter, Erin Flatley, et al.Blood Advances|July 25, 2020
Treosulfan-based conditioning is feasible and effective for cord blood recipients: a phase 2 multicenter studyFilippo Milano, Jonathan A Gutman, H Joachim Deeg, et al.Neuron|October 20, 2023
Radial astrocyte synchronization modulates the visual system during behavioral-state transitionsAlejandro Uribe-Arias, Rotem Rozenblat, Ehud Vinepinsky, et al.Blood Advances|October 5, 2024
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemiaKhushboo V Pal, Megan Othus, Zahra Ali, et al.Bone Marrow Transplantation|October 11, 2001
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimensF Gutierrez-Delgado, D G Maloney, O W Press, et al.Neurology|August 1, 1986
Myasthenia gravis after allogeneic bone marrow transplantation: relationship to chronic graft-versus-host diseaseG B Bolger, K M Sullivan, A M Spence, et al.Cancer|February 1, 1994
Human anti-mouse antibody suppression with cyclosporin AP L Weiden, S B Wolf, H B Breitz, et al.Pageof 239